世界のバイオセンサー市場(~2026年):種類別、製品別(ウェアラブル、非ウェアラブル)、技術別、用途別(POC、家庭診断、研究所、環境モニタリング、食品&飲料、バイオディフェンス)、地域別

調査会社MarketsandMarkets社が発行したリサーチレポート(データ管理コード:SE3097)
◆英語タイトル:Biosensors Market with COVID-19 Impact by Type, Product (Wearable, Non-wearable), Technology, Application (POC, Home Diagnostics, Research Lab, Environmental Monitoring, Food & Beverages, Biodefense) and Region - Global Forecast to 2026
◆発行会社/調査会社:MarketsandMarkets
◆商品コード:SE3097
◆発行日:2029年4月23日
◆調査対象地域:グローバル
◆産業分野:バイオ
◆ページ数:223
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後24時間以内)
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥544,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界のバイオセンサー市場(~2026年):種類別、製品別(ウェアラブル、非ウェアラブル)、技術別、用途別(POC、家庭診断、研究所、環境モニタリング、食品&飲料、バイオディフェンス)、地域別]についてメールでお問い合わせはこちら
マーケッツアンドマーケッツ社は、世界のバイオセンサー市場規模が2021年255億ドルから2026年367億ドルまで、年平均7.5%成長すると予測しています。本調査レポートでは、バイオセンサーの世界市場を調査対象とし、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、種類別(センサーパッチ、組み込み機器)分析、製品別(ウェアラブル、非ウェアラブル)分析、技術別(電気化学バイオセンサー、光学バイオセンサー、圧電バイオセンサー、熱バイオセンサー、ナノメカニカルバイオセンサー)分析、コンポーネント別(生体受容体分子、生物学的要素、トランスデューサー)分析、地域別分析、競争状況、企業情報などを整理しました。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界のバイオセンサー市場規模:種類別(センサーパッチ、組み込み機器)
・世界のバイオセンサー市場規模:製品別(ウェアラブル、非ウェアラブル)
・世界のバイオセンサー市場規模:技術別(電気化学バイオセンサー、光学バイオセンサー、圧電バイオセンサー、熱バイオセンサー、ナノメカニカルバイオセンサー)
・世界のバイオセンサー市場規模:コンポーネント別(生体受容体分子、生物学的要素、トランスデューサー)
・世界のバイオセンサー市場規模:地域別
・競争状況
・企業情報
*** レポート概要(サマリー)***

“The biosensors market is valued at USD 25.5 billion in 2021 and is projected to reach USD 36.7 billion by 2026; it is expected to grow at a CAGR of 7.5% from 2021 to 2026.”
Metal-based nanoparticles can be efficiently used to detect nucleic acid sequences by exploiting their optoelectronic properties. Recent advancements in the field of nanotechnology have led to the utilization of nanomaterials, such as metal nanoparticles, oxide nanoparticles, magnetic nanomaterials, carbon materials, quantum dots, and metallophthalocyanines, to improve the electrochemical signals of biocatalytic events that occur at electrode/electrolyte interface. Nanomaterials, such as carbon nanotubes and indium oxide nanowires, are widely used to manufacture nanotechnology-based biosensors or nanobiosensors. Nanobiosensors have revolutionized the future of disease diagnosis. They are gaining importance in areas such as catalysis, optics, biomedical sciences, mechanics, magnetic, and energy science.

“The cost pressure is adversely affecting the growth of the global POC market.”
This is attributed to reimbursement cuts and lack of sufficient budgets. For instance, in 2013, the US government passed the healthcare reform bill, according to which, manufacturers have to pay a heavy 2.3% annual excise tax on medical devices. Similarly, France has explicitly targeted medical devices for cost containment to recover from the recession. The 2013 French budget included price cuts to the tune of USD 157.6 million on the medical sector (including POC), leading to savings of USD 102.8 million from the ambulatory care sector and USD 54.8 million from hospitals. Expenditure on medical devices (including POC) worldwide is also at risk due to a decrease in the list of healthcare products eligible for reimbursements. These factors create pressure on the global medical devices industry. As a result, manufacturers are finding it increasingly challenging to support prices and preclude margin erosion, with rising competition. Thus, price-cutting measures on medical devices, including POC diagnostics, will pose a key challenge to the growth of the market in the coming years.

“Sensor Patch Devices: The fastest type of biosensors market .”
Sensor patches are devices that are attached to a human body for monitoring a range of vital signs and providing specific treatments when required. Sensor patches are categorized under wearable devices, which have embedded intelligence, connectivity, and increased usability. Sensor patches offer unique opportunities for condition/activity monitoring, feedback, and actuation/delivery services, such as drug delivery or stimulation, localization, identification, personal contextual notifications, information display, and virtual assistance. In simpler terms, these devices can monitor, document, and augment lives, and they can be used to assist people in specialized professional and personal activities. These devices also help in sending information directly to caregivers, as well as allowing remote patient monitoring and detecting diseases at early stages.

“Wearable Biosensors: The fastest product segment of the biosensors market .”
Wearable biosensors have attracted considerable attention because of their potential to change the classical medical diagnostics and continuous health monitoring concepts. Wearable biosensor applications aim to change centralized hospital-based care systems to home-based personal medicine and reduce healthcare cost and time for diagnosis. Nowadays, we can see that wearable biosensors are bringing out a wave of innovation to society. Their comfort and better use can provide a new level of exposure to a patient’s real-time health status. This real-time data availability allows better clinical decisions and results in better health results and more efficient use of health systems. For human society, wearable biosensors may help in the early detection of health events and the avoidance of hospitalization. Such events are expected to boost the market growth of wearable biosensors.

“Home Diagnostics: Fastest growing application of Biosensors market”
Home diagnostics are not limited to checking body weight and measuring body temperature during sickness, it also includes monitoring health and fitness at home without the intervention of physicians. Tests to monitor blood glucose level, fertility, cholesterol, HIV, vitamin D, influenza, and testosterone can be conducted at home by taking a small sample and loading it into a testing cartridge of biosensor units. These biosensor units are intelligent enough to sense the information and transfer it to the consumer’s smartphone through Bluetooth, providing instant test results and suggestions for improving health. Home diagnostics offers various advantages, such as privacy, convenience, and ease-of-use, and low cost.

“North America: The leading region in the global biosensors market .”
North America is projected to account for the largest size of the global biosensors market from 2021 to 2026. The presence of key industrial players and the early adoption of new technological advancements such as nanotechnology are the main factors for the growth of the biosensors market in North America. The market’s growth is mostly driven by the rise in funding for the research and development of medical devices containing biosensors. Research and development of medical devices are largely dependent on funding and grants. For instance, in 2017, Senseonics Holdings (US), a medical technology company, raised USD 41 million to commercialize its Eversense continuous glucose monitoring system and to support research and development for next-generation versions of the sensor. Similarly, in 2016, Endotronix (US), a developer of wireless and implantable pressure sensors, raised USD 32 million in a series C round of financing. These investments resulted in the development of biosensors for a range of medical equipment and this drove the market in the historic period.

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:
• By Company Type: Tier 1 – 40%, Tier 2 – 25%, and Tier 3 – 35%
• By Designation: C-level Executives – 35%, Directors – 28%, and Others – 37%
• By Region: North America – 48%, Europe – 22%, APAC – 20%, RoW – 10%

Abbott (US), Roche (Switzerland), Medtronic (Ireland), Bio-Rad Laboratories, Inc. (US), DuPont (US), Biosensors International Group, Ltd. (Singapore), Cytiva (UK), Dexcom, Inc. (US), Lifescan IP Holdings, LLC (US), Masimo (US), Nova Biomedical (US), Universal Biosensors (Australia), ACON Laboratories, Inc. (US), CARDEA BIO INC., (US), Conductive Technologies (US), EarlySense (Israel), Innovative Sensor Technology IST AG (Switzerland), LifeSignals (US), NeuroSky (US), Pinnacle Technology Inc. (US), SD Biosensor, INC. (South Korea), VitalConnect (US), and Xsensio (Switzerland) are a few of the key players in the biosensors market.

Research Coverage:
The report segments the biosensors market and forecasts its size, by value, based on Type(Sensor Patch, Embedded Device), Product (Wearable Biosensors, Non-Wearable Biosensors), Technology (Electrochemical, Optical, Piezoelectric, Thermal, Nanomechanical), Application (POC, Home Diagnostics, Research Labs, Environmental Monitoring, Food & Beverages, Biodefense), and Region (North America, Europe, APAC, and RoW),.
The report also provides a comprehensive review of market drivers, restraints, opportunities, and challenges in the biosensors market. The report also covers qualitative aspects in addition to the quantitative aspects of these markets.

Key Benefits of Buying the Report
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the biosensors market and provides them information on key market drivers, restraints, challenges, and opportunities.Report also covers COVID-19 impact on biosensors market .

*** レポート目次(コンテンツ)***

1 INTRODUCTION 27
1.1 STUDY OBJECTIVES 27
1.2 DEFINITION AND SCOPE 27
1.3 STUDY SCOPE 28
FIGURE 1 BIOSENSORS MARKET SEGMENTATION 28
1.3.1 GEOGRAPHIC SCOPE 28
1.3.2 INCLUSIONS AND EXCLUSIONS 29
1.4 YEARS CONSIDERED 29
1.5 CURRENCY 30
1.6 STAKEHOLDERS 30
1.7 SUMMARY OF CHANGES 30
2 RESEARCH METHODOLOGY 31
2.1 RESEARCH DATA 31
FIGURE 2 BIOSENSORS MARKET: PROCESS FLOW OF MARKET SIZE ESTIMATION 31
FIGURE 3 BIOSENSORS MARKET: RESEARCH DESIGN 32
2.1.1 SECONDARY DATA 32
2.1.1.1 Secondary sources 33
2.1.2 PRIMARY DATA 33
2.1.2.1 Key industry insights 34
2.1.2.2 Breakdown of primaries 34
2.1.2.3 Key data from primary sources 35
2.2 MARKET SIZE ESTIMATION 36
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: SUPPLY-SIDE ANALYSIS 36
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 2 (SUPPLY SIDE) – IDENTIFICATION OF REVENUES GENERATED BY COMPANIES FROM MICRO SERVER OFFERINGS 37
2.2.1 BOTTOM-UP APPROACH 38
2.2.1.1 Approach for arriving at market size using bottom-up analysis (demand side) 38
FIGURE 6 BIOSENSORS MARKET: BOTTOM-UP APPROACH 38
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR ESTIMATING SIZE OF BIOSENSORS MARKET 39
2.2.2 TOP-DOWN APPROACH 39
2.2.2.1 Approach for arriving at market size using top-down analysis
(supply side) 40
FIGURE 8 BIOSENSORS MARKET: TOP-DOWN APPROACH 40
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 41
FIGURE 9 DATA TRIANGULATION METHODOLOGY 41

2.4 RESEARCH ASSUMPTIONS 42
TABLE 1 STUDY ASSUMPTIONS 42
2.5 LIMITATIONS 43
FIGURE 10 LIMITATIONS OF STUDY 43
3 EXECUTIVE SUMMARY 44
FIGURE 11 BIOSENSOR MARKET FOR SENSOR PATCH IS EXPECTED TO GROW AT HIGHER RATE DURING FORECAST PERIOD 45
FIGURE 12 MARKET FOR WEARABLE BIOSENSORS IS EXPECTED TO GROW AT HIGHER RATE DURING FORECAST PERIOD 46
FIGURE 13 BIOSENSORS MARKET FOR ELECTROCHEMICAL TECHNOLOGY TO HOLD LARGEST SHARE IN 2026 46
FIGURE 14 POINT OF CARE APPLICATIONS HELD LARGEST SHARE OF BIOSENSORS MARKET IN 2021 47
FIGURE 15 BIOSENSORS MARKET IN APAC TO GROW AT HIGHEST CAGR FROM
2021 TO 2026 48
4 PREMIUM INSIGHTS 50
4.1 ATTRACTIVE OPPORTUNITIES IN BIOSENSORS MARKET 50
FIGURE 16 RISING DEMAND FOR WEARABLE DEVICES ACROSS VARIOUS COUNTRIES TO IMPLEMENT MORE BIOSENSORS ACROSS POC AND HOME DIAGNOSTIC APPLICATIONS 50
4.2 BIOSENSORS MARKET IN NORTH AMERICA, BY COUNTRY AND BY PRODUCT 51
FIGURE 17 US AND NON-WEARABLE DEVICES ARE EXPECTED TO HOLD LARGEST SHARE OF NORTH AMERICAN BIOSENSORS MARKET IN 2021 51
4.3 BIOSENSORS MARKET IN APAC, BY APPLICATION 51
FIGURE 18 POC APPLICATION TO HOLD LARGEST SHARE OF BIOSENSORS MARKET IN APAC DURING FORECAST PERIOD 51
4.4 BIOSENSORS MARKET, BY COUNTRY 52
FIGURE 19 BIOSENSORS MARKET IN CHINA TO GROW AT HIGHEST CAGR FROM
2021 TO 2026 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
FIGURE 20 INCREASED DEMAND FOR HOME-BASED POC DEVICES DUE TO COVID-19 PANDEMIC TO DRIVE MARKET FOR BIOSENSORS 53
FIGURE 21 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF BIOSENSORS MARKET 54
5.2.1 DRIVERS 56
5.2.1.1 Emergence of nanotechnology-based biosensors 56
5.2.1.2 Significant technological advancements in last few years 57
5.2.1.3 Increasing use of biosensors to monitor glucose levels in individuals with diabetes 58
5.2.1.4 Surging demand for home-based point-of-care devices due to COVID-19 pandemic 58
5.2.1.5 Rising government initiatives toward diagnostics 59
5.2.2 RESTRAINTS 59
5.2.2.1 Slow rate of commercialization and reluctance in adopting new treatment practices 59
5.2.2.2 High costs involved in R&D 60
5.2.3 OPPORTUNITIES 60
5.2.3.1 Emerging market in developing countries 60
5.2.3.2 High-growth opportunities in food industry and environmental monitoring applications 60
5.2.3.3 High-growth opportunities in wearable device market 61
5.2.4 CHALLENGES 61
5.2.4.1 Government regulations—long certification and approval cycles 61
5.2.4.2 Pricing pressure in POC market 62
5.3 VALUE CHAIN ANALYSIS 62
FIGURE 22 BIOSENSOR MANUFACTURERS CONTRIBUTE MAJOR VALUE TO OVERALL COST OF BIOSENSORS 62
5.4 BIOSENSORS ECOSYSTEM 63
FIGURE 23 BIOSENSORS MARKET ECOSYSTEM 63
TABLE 2 SUPPLY CHAIN 64
5.5 PORTER’S FIVE FORCES ANALYSIS 65
TABLE 3 BIOSENSORS MARKET: PORTER’S FIVE FORCES ANALYSIS 65
5.5.1 DEGREE OF COMPETITION 65
5.5.2 BARGAINING POWER OF SUPPLIERS 65
5.5.3 BARGAINING POWER OF BUYERS 66
5.5.4 THREAT FROM SUBSTITUTES 66
5.5.5 THREAT FROM NEW ENTRANTS 66
5.6 CASE STUDIES FOR BIOSENSORS MARKET 66
5.6.1 I-STAT SYSTEM HELPS PATIENTS AT ROCHDALE URGENT CARE CENTER 66
5.6.2 INTEGRATED HEALTH SOLUTION PROVIDED COST SAVINGS AND INCREASED EFFICIENCY 66
5.6.3 REDUCING MATERNAL MORBIDITY AND MORTALITY THROUGH NON-INVASIVE HAEMOGLOBIN MONITORING 67
5.6.4 IMPROVING MOBILITY FOR PATIENTS AND REDUCING FALSE ALARMS FOR STAFF AT SUB-ACUTE CHILDREN’S HOSPITAL 67
5.6.5 ENABLING SEAMLESS DATA TRANSMISSION FROM PATIENT’S HOME 67
5.7 TECHNOLOGY ANALYSIS 68
5.8 AVERAGE SELLING PRICE (ASP) TREND ANALYSIS 69
FIGURE 24 AVERAGE SELLING PRICE OF BIOSENSORS, BY PRODUCT (USD) 69
5.9 TRADE ANALYSIS 70
TABLE 4 EXPORT SCENARIO FOR HS CODE: 901890, BY COUNTRY,
2015–2019 (USD THOUSAND) 70
TABLE 5 IMPORT SCENARIO FOR HS CODE: 901890, BY COUNTRY,
2015–2019 (USD THOUSAND) 70
5.10 PATENT ANALYSIS 71
5.11 STANDARDS AND REGULATIONS RELATED TO BIOSENSORS MARKET 72
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES 73
FIGURE 25 REVENUE SHIFT FOR BIOSENSORS MARKET 73
6 BIOSENSORS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
FIGURE 26 BIOSENSOR MARKET FOR SENSOR PATCH IS EXPECTED TO GROW AT HIGHER RATE DURING FORECAST PERIOD 75
TABLE 6 BIOSENSORS MARKET, BY TYPE, 2017–2020 (USD BILLION) 75
TABLE 7 BIOSENSORS MARKET, BY TYPE, 2021–2026 (USD BILLION) 75
6.2 SENSOR PATCH 76
6.2.1 THESE DEVICES ASSIST PEOPLE IN SPECIALIZED PROFESSIONAL AND PERSONAL ACTIVITIES 76
FIGURE 27 BIOSENSOR MARKET FOR SENSOR PATCH IN NORTH AMERICA HOLDS LARGEST SHARE 77
TABLE 8 BIOSENSORS MARKET FOR SENSOR PATCH, BY REGION,
2017–2020 (USD MILLION) 77
TABLE 9 BIOSENSORS MARKET FOR SENSOR PATCH, BY REGION,
2021–2026 (USD MILLION) 77
6.3 EMBEDDED DEVICE 78
6.3.1 THEY DETECT BROAD SPECTRUM OF BIOLOGICAL ANALYTES AND SHOW GREATER RESPONSES AND SUCCESS RATES IN MEDICAL LABORATORIES AND FOOD BIOANALYSES 78
TABLE 10 BIOSENSORS MARKET FOR EMBEDDED DEVICE, BY REGION,
2017–2020 (USD BILLION) 78
TABLE 11 BIOSENSORS MARKET FOR EMBEDDED DEVICE, BY REGION,
2021–2026 (USD BILLION) 78
7 BIOSENSORS MARKET, BY PRODUCT 79
7.1 INTRODUCTION 80
FIGURE 28 MARKET FOR WEARABLE BIOSENSORS IS EXPECTED TO GROW AT HIGHER RATE DURING FORECAST PERIOD 80
TABLE 12 BIOSENSORS MARKET, BY PRODUCT, 2017–2020 (USD BILLION) 80
TABLE 13 BIOSENSORS MARKET, BY PRODUCT, 2021–2026 (USD BILLION) 80
TABLE 14 BIOSENSORS MARKET, BY PRODUCT, 2020–2026 (MILLION UNITS) 81
7.2 WEARABLE BIOSENSORS 81
FIGURE 29 WEARABLE BIOSENSORS MARKET IN APAC IS EXPECTED TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 82
TABLE 15 WEARABLE BIOSENSORS MARKET, BY REGION, 2017–2020 (USD BILLION) 82
TABLE 16 WEARABLE BIOSENSORS MARKET, BY REGION, 2021–2026 (USD BILLION) 82
TABLE 17 WEARABLE BIOSENSORS MARKET, BY TECHNOLOGY, 2017–2020 (USD BILLION) 83
TABLE 18 WEARABLE BIOSENSORS MARKET, BY TECHNOLOGY, 2021–2026 (USD BILLION) 83
7.2.1 WRISTWEAR 83
7.2.1.1 Offer real-time health and fitness tracking and monitoring 83

7.2.2 EYEWEAR 83
7.2.2.1 Smart glasses and smart lenses to have significant presence in market in coming years 83
7.2.3 FOOTWEAR 84
7.2.3.1 Help in monitoring kilometer run, calories burned, workout hours, blood pressure, and other fitness- and health-related data 84
7.2.4 NECKWEAR 84
7.2.4.1 Trendy devices that can help monitor fitness 84
7.2.5 BODYWEAR 84
7.2.5.1 Have potential to equip clothes used for daily wear with smart capabilities, making detection of body movements possible 84
7.2.6 OTHERS 85
TABLE 19 WEARABLE BIOSENSORS MARKET, BY PRODUCT, 2017–2020 (USD BILLION) 85
TABLE 20 WEARABLE BIOSENSORS MARKET, BY PRODUCT, 2021–2026 (USD BILLION) 85
7.3 NON-WEARABLE BIOSENSORS 86
7.3.1 OFFER REAL-TIME ON-SITE MONITORING OF PRODUCTION PROCESSES 86
TABLE 21 NON-WEARABLE BIOSENSORS MARKET, BY REGION,
2017–2020 (USD BILLION) 86
TABLE 22 NON-WEARABLE BIOSENSORS MARKET, BY REGION,
2021–2026 (USD BILLION) 86
TABLE 23 NON-WEARABLE BIOSENSORS MARKET, BY TECHNOLOGY,
2017–2020 (USD BILLION) 86
TABLE 24 NON-WEARABLE BIOSENSORS MARKET, BY TECHNOLOGY,
2021–2026 (USD BILLION) 87
7.4 IMPACT OF COVID-19 87
8 BIOSENSORS MARKET, BY TECHNOLOGY 88
8.1 INTRODUCTION 89
FIGURE 30 BIOSENSORS MARKET FOR ELECTROCHEMICAL TECHNOLOGY TO HOLD LARGEST SHARE IN 2026 89
TABLE 25 BIOSENSORS MARKET, BY TECHNOLOGY, 2017–2020 (USD BILLION) 89
TABLE 26 BIOSENSORS MARKET, BY TECHNOLOGY, 2021–2026 (USD BILLION) 90
8.2 ELECTROCHEMICAL BIOSENSORS 90
TABLE 27 BIOSENSORS MARKET FOR ELECTROCHEMICAL TECHNOLOGY,
BY PRODUCT, 2017–2020 (USD BILLION) 91
TABLE 28 BIOSENSORS MARKET FOR ELECTROCHEMICAL TECHNOLOGY,
BY PRODUCT, 2021–2026 (USD BILLION) 91
8.2.1 AMPEROMETRIC SENSORS 91
8.2.1.1 Blood glucose sensors 91
8.2.1.1.1 Suitable for medical devices for monitoring blood glucose 91
TABLE 29 GLUCOSE SENSORS AND DEVICES APPROVED BY FDA DURING 2019–2020 92
8.2.2 POTENTIOMETRIC SENSORS 92
8.2.2.1 Immunosensors 92
8.2.2.1.1 Enable label-free detection and quantification of immune complex 92
8.2.3 CONDUCTOMETRIC SENSORS 93
8.2.3.1 Conductometric devices can be used to study enzymatic reactions and for practical applications, including drug detection in human urine and pollutant detection in environmental testing 93
8.3 OPTICAL BIOSENSORS 93
FIGURE 31 OPTICAL TECHNOLOGY FOR WEARABLE DEVICES IS EXPECTED TO EXPERIENCE HIGHEST GROWTH RATE IN BIOSENSORS MARKET DURING FORECAST PERIOD 94
TABLE 30 BIOSENSORS MARKET FOR OPTICAL TECHNOLOGY, BY PRODUCT,
2017–2020 (USD BILLION) 94
TABLE 31 BIOSENSORS MARKET FOR OPTICAL TECHNOLOGY, BY PRODUCT,
2021–2026 (USD BILLION) 94
8.3.1 SPR 95
8.3.1.1 Measure interactions in real-time with high sensitivity and without needing labels 95
8.3.2 COLORIMETRIC BIOSENSORS 95
8.3.2.1 Used in various applications, such as detection and identification of virulence activities 95
8.3.3 FLUORESCENCE BIOSENSORS 95
8.3.3.1 Provide better sensitivities and specificities, as well as ease of labeling, while detection 95
8.4 PIEZOELECTRIC BIOSENSORS 96
TABLE 32 BIOSENSORS MARKET FOR PIEZOELECTRIC TECHNOLOGY, BY PRODUCT, 2017–2020 (USD BILLION) 96
TABLE 33 BIOSENSORS MARKET FOR PIEZOELECTRIC TECHNOLOGY, BY PRODUCT, 2021–2026 (USD BILLION) 96
8.4.1 ACOUSTIC BIOSENSORS 96
8.4.1.1 Monitor changes in physical properties of acoustic waves in response to measurand 96
8.4.2 MICROCANTILEVER BIOSENSORS 97
8.4.2.1 Promising tool for detecting biomolecular interactions with improved accuracy 97
8.5 THERMAL BIOSENSORS 97
8.5.1 DO NOT REQUIRE FREQUENT RECALIBRATION AND ARE INSENSITIVE TO OPTICAL AND ELECTROCHEMICAL PROPERTIES OF SAMPLE 97
TABLE 34 BIOSENSORS MARKET FOR THERMAL TECHNOLOGY, BY PRODUCT,
2017–2020 (USD BILLION) 97
TABLE 35 BIOSENSORS MARKET FOR THERMAL TECHNOLOGY, BY PRODUCT,
2021–2026 (USD BILLION) 98
8.6 NANOMECHANICAL BIOSENSORS 98
8.6.1 HAVE ABILITY TO PERFORM RAPID, SENSITIVE, AND SELECTIVE DETECTION OF BIOLOGICAL AND BIOCHEMICAL ENTITIES 98
TABLE 36 BIOSENSORS MARKET FOR NANOMECHANICAL TECHNOLOGY, BY PRODUCT, 2017–2020 (USD BILLION) 98
TABLE 37 BIOSENSORS MARKET FOR NANOMECHANICAL TECHNOLOGY, BY PRODUCT, 2021–2026 (USD BILLION) 99

9 BIOSENSORS MARKET, BY COMPONENT 100
9.1 INTRODUCTION 100
9.2 BIORECEPTOR MOLECULES 100
9.2.1 PRESENTLY, ANTIBODIES AND PROTEINS ARE ALSO USED AS BIORECEPTOR MOLECULES IN BIOSENSORS 100
9.3 BIOLOGICAL ELEMENT 100
9.3.1 BIOLOGICAL ELEMENTS ARE MATERIALS RELATED TO BIOMOLECULES 100
9.4 TRANSDUCER 100
9.4.1 TRANSDUCER IS MOST IMPORTANT COMPONENT OF BIOSENSORS,
IT COVERTS BIOCHEMICAL ACTIVITIES INTO ELECTRICAL SIGNALS 100
10 BIOSENSORS MARKET, BY APPLICATION 101
10.1 INTRODUCTION 102
FIGURE 32 POINT OF CARE APPLICATIONS HELD LARGEST MARKET SHARE OF BIOSENSORS MARKET IN 2021 102
TABLE 38 BIOSENSORS MARKET, BY APPLICATION, 2017–2020 (USD MILLION) 102
TABLE 39 BIOSENSORS MARKET, BY APPLICATION, 2021–2026 (USD MILLION) 103
10.2 POC 103
TABLE 40 BIOSENSORS MARKET FOR POC APPLICATION, BY TYPE,
2017–2020 (USD BILLION) 104
TABLE 41 BIOSENSORS MARKET FOR POC APPLICATION, BY TYPE,
2021–2026 (USD BILLION) 104
TABLE 42 BIOSENSORS MARKET FOR POC APPLICATION, BY REGION,
2017–2020 (USD BILLION) 105
TABLE 43 BIOSENSORS MARKET FOR POC APPLICATION, BY REGION,
2021–2026 (USD BILLION) 105
10.2.1 GLUCOSE MONITORING 105
10.2.1.1 Rising prevalence of diabetes worldwide, technological advancements in self-monitoring of blood glucose, and growing awareness about PoC testing 105
TABLE 44 BIOSENSORS MARKET FOR GLUCOSE MONITORING FOR POC APPLICATION, BY REGION, 2017–2020 (USD BILLION) 106
TABLE 45 BIOSENSORS MARKET FOR GLUCOSE MONITORING FOR POC APPLICATION, BY REGION, 2021–2026 (USD BILLION) 106
10.2.2 CARDIAC MARKER 106
10.2.2.1 Sedentary urban lifestyles causing increase in cardiovascular diseases 106
TABLE 46 BIOSENSORS MARKET FOR CARDIAC MARKER FOR POC APPLICATION,
BY REGION, 2017–2020 (USD MILLION) 107
TABLE 47 BIOSENSORS MARKET FOR CARDIAC MARKER FOR POC APPLICATION,
BY REGION, 2021–2026 (USD MILLION) 107
10.2.3 INFECTIOUS DISEASE DETECTION 107
10.2.3.1 Detection of toxins, bacteria, and viruses in variety of physiological and environmental matrices 107
FIGURE 33 INFECTIOUS DISEASE DETECTION OF POC APPLICATION HOLDS LARGEST MARKET SHARE ACROSS NORTH AMERICA DURING FORECAST PERIOD 108
TABLE 48 BIOSENSORS MARKET FOR INFECTIOUS DISEASE DETECTION FOR POC APPLICATION, BY REGION, 2017–2020 (USD MILLION) 108
TABLE 49 BIOSENSORS MARKET FOR INFECTIOUS DISEASE DETECTION FOR POC APPLICATION, BY REGION, 2021–2026 (USD MILLION) 108
10.2.4 COAGULATION MONITORING 109
10.2.4.1 Growing use of anticoagulant therapy, coupled with adoption of self-testing kits for use at home 109
TABLE 50 BIOSENSORS MARKET FOR COAGULATION MONITORING FOR POC APPLICATION, BY REGION, 2017–2020 (USD MILLION) 109
TABLE 51 BIOSENSORS MARKET FOR COAGULATION MONITORING FOR POC APPLICATION, BY REGION, 2021–2026 (USD MILLION) 109
10.2.5 PREGNANCY TESTING 110
10.2.5.1 Growing preference of women for confidentiality and accessibility of test results 110
TABLE 52 BIOSENSORS MARKET FOR PREGNANCY TESTING FOR POC APPLICATION,
BY REGION, 2017–2020 (USD MILLION) 110
TABLE 53 BIOSENSORS MARKET FOR PREGNANCY TESTING FOR POC APPLICATION,
BY REGION, 2021–2026 (USD MILLION) 110
10.2.6 BLOOD GAS & ELECTROLYTE DETECTION 111
10.2.6.1 Growing global aging population is significantly driving growth of market 111
TABLE 54 BIOSENSORS MARKET FOR BLOOD GAS & ELECTROLYTE DETECTION FOR POC APPLICATION, BY REGION, 2017–2020 (USD MILLION) 111
TABLE 55 BIOSENSORS MARKET FOR BLOOD GAS & ELECTROLYTE DETECTION FOR POC APPLICATION, BY REGION, 2021–2026 (USD MILLION) 111
10.2.7 DETECTION OF TUMOR OR CANCER MARKER 111
10.2.7.1 Increasing number of people suffering from cancer and growth in investments in cancer research 111
TABLE 56 BIOSENSORS MARKET FOR TUMOR OR CANCER MARKER FOR POC APPLICATION, BY REGION, 2017–2020 (USD MILLION) 112
TABLE 57 BIOSENSORS MARKET FOR TUMOR OR CANCER MARKER FOR POC APPLICATION, BY REGION, 2021–2026 (USD MILLION) 112
10.2.8 URINALYSIS TESTING 112
10.2.8.1 Rising number of urinary tract infections among individuals 112
TABLE 58 BIOSENSORS MARKET FOR URINALYSIS TESTING FOR POC APPLICATION,
BY REGION, 2017–2020 (USD MILLION) 113
TABLE 59 BIOSENSORS MARKET FOR URINALYSIS TESTING FOR POC APPLICATION,
BY REGION, 2021–2026 (USD MILLION) 113
10.2.9 CHOLESTEROL TESTING 113
10.2.9.1 Increasing prevalence of CVDs due to aging and obese population 113
TABLE 60 BIOSENSORS MARKET FOR CHOLESTEROL TESTING FOR POC APPLICATION, BY REGION, 2017–2020 (USD MILLION) 114
TABLE 61 BIOSENSORS MARKET FOR CHOLESTEROL TESTING FOR POC APPLICATION, BY REGION, 2021–2026 (USD MILLION) 114
10.3 HOME DIAGNOSTICS 114
TABLE 62 BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATION, BY TYPE, 2017–2020 (USD MILLION) 114
TABLE 63 BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATION, BY TYPE, 2021–2026 (USD MILLION) 115
FIGURE 34 BIOSENSORS MARKET FOR HOME DIAGNOSTIC APPLICATIONS IN APAC IS EXPECTED TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 115
TABLE 64 BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATION, BY REGION. 2017–2020 (USD BILLION) 115
TABLE 65 BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATION, BY REGION, 2021–2026 (USD BILLION) 116
10.3.1 GLUCOSE MONITORING 116
10.3.1.1 Growing preference for self-monitoring blood glucose devices 116
TABLE 66 BIOSENSORS MARKET FOR GLUCOSE MONITORING FOR HOME DIAGNOSTICS APPLICATION, BY REGION, 2017–2020 (USD BILLION) 116
TABLE 67 BIOSENSORS MARKET FOR GLUCOSE MONITORING FOR HOME DIAGNOSTICS APPLICATION, BY REGION, 2021–2026 (USD BILLION) 117
10.3.2 PREGNANCY TESTING 117
10.3.2.1 Need for portable and user-friendly pregnancy testing devices 117
TABLE 68 BIOSENSORS MARKET FOR PREGNANCY TESTING FOR HOME DIAGNOSTIC APPLICATION, BY REGION, 2017–2020 (USD MILLION) 117
TABLE 69 BIOSENSORS MARKET FOR PREGNANCY TESTING FOR HOME DIAGNOSTIC APPLICATION, BY REGION, 2021–2026 (USD MILLION) 118
10.3.3 CHOLESTEROL TESTING 118
10.3.3.1 Growth of diseases due to increased cholesterol levels in individuals 118
TABLE 70 BIOSENSORS MARKET FOR CHOLESTEROL TESTING FOR HOME DIAGNOSTICS APPLICATION, BY REGION, 2017–2020 (USD MILLION) 118
TABLE 71 BIOSENSORS MARKET FOR CHOLESTEROL TESTING FOR HOME DIAGNOSTICS APPLICATION, BY REGION, 2021–2026 (USD MILLION) 119
10.4 RESEARCH LABS 119
10.4.1 NEED FOR BIOSENSOR-BASED PRODUCT DEVELOPMENT FOR EARLY MONITORING OF DISEASES 119
TABLE 72 BIOSENSORS MARKET FOR RESEARCH LAB APPLICATION, BY REGION, 2017–2020 (USD BILLION) 119
TABLE 73 BIOSENSORS MARKET FOR RESEARCH LAB APPLICATION, BY REGION, 2021–2026 (USD BILLION) 120
10.5 ENVIRONMENTAL MONITORING 120
10.5.1 DETECTION OF CONTAMINANTS IN COMPLEX MATRICES WITH SEVERAL ADVANTAGES TO ENHANCE MARKET GROWTH 120
TABLE 74 BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATION,
BY REGION, 2017–2020 (USD BILLION) 121
TABLE 75 BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATION,
BY REGION, 2021–2026 (USD BILLION) 121
10.6 FOOD & BEVERAGES 121
10.6.1 BIOSENSORS ARE USED FOR PATHOGEN DETECTION AND ARE HELPING TO MEET STRINGENT FOOD STANDARDS 121
TABLE 76 BIOSENSORS MARKET FOR FOOD & BEVERAGES APPLICATION, BY REGION, 2017–2020 (USD BILLION) 122
TABLE 77 BIOSENSORS MARKET FOR FOOD & BEVERAGES APPLICATION, BY REGION, 2021–2026 (USD BILLION) 122

10.7 BIODEFENSE 122
10.7.1 USE OF BIOSENSORS TO DETECT MICROBIAL PATHOGENS DURING BIOLOGICAL WARFARE 122
TABLE 78 BIOSENSORS MARKET FOR BIODEFENSE APPLICATION, BY REGION,
2017–2020 (USD MILLION) 123
TABLE 79 BIOSENSORS MARKET FOR BIODEFENSE APPLICATION, BY REGION,
2021–2026 (USD MILLION) 123
11 GEOGRAPHIC ANALYSIS 124
11.1 INTRODUCTION 125
FIGURE 35 NORTH AMERICA HOLDS LARGEST SHARE OF BIOSENSORS MARKET 125
TABLE 80 BIOSENSORS MARKET BY REGION, 2017–2020 (USD BILLION) 125
TABLE 81 BIOSENSORS MARKET BY REGION, 2021–2026 (USD BILLION) 126
11.2 NORTH AMERICA 126
FIGURE 36 SNAPSHOT: BIOSENSORS MARKET IN NORTH AMERICA 127
TABLE 82 BIOSENSORS MARKET IN NORTH AMERICA, BY APPLICATION,
2017–2020 (USD BILLION) 128
TABLE 83 BIOSENSORS MARKET IN NORTH AMERICA, BY APPLICATION,
2021–2026 (USD BILLION) 128
TABLE 84 BIOSENSORS MARKET IN NORTH AMERICA, BY POC APPLICATION,
2017–2020 (USD BILLION) 128
TABLE 85 BIOSENSORS MARKET IN NORTH AMERICA, BY POC APPLICATION,
2021–2026 (USD BILLION) 129
TABLE 86 BIOSENSORS MARKET IN NORTH AMERICA, BY HOME DIAGNOSTICS APPLICATION, 2017–2020 (USD MILLION) 129
TABLE 87 BIOSENSORS MARKET IN NORTH AMERICA, BY HOME DIAGNOSTICS APPLICATION, 2021–2026 (USD MILLION) 129
TABLE 88 BIOSENSORS MARKET FOR NORTH AMERICA, BY TYPE,
2017–2020 (USD BILLION) 130
TABLE 89 BIOSENSORS MARKET FOR NORTH AMERICA, BY TYPE,
2021–2026 (USD BILLION) 130
TABLE 90 BIOSENSORS MARKET FOR NORTH AMERICA, BY PRODUCT,
2017–2020 (USD BILLION) 130
TABLE 91 BIOSENSORS MARKET FOR NORTH AMERICA, BY PRODUCT,
2021–2026 (USD BILLION) 130
FIGURE 37 US HOLDS LARGEST SHARE OF BIOSENSORS MARKET 131
TABLE 92 BIOSENSORS MARKET IN NORTH AMERICA, BY COUNTRY,
2017–2020 (USD BILLION) 131
TABLE 93 BIOSENSORS MARKET IN NORTH AMERICA, BY COUNTRY,
2021–2026 (USD BILLION) 131
11.2.1 US 132
11.2.1.1 Presence of key players that offer biosensor-based PoC applications in US 132
11.2.2 CANADA 132
11.2.2.1 Increasing government support likely to escalate growth of biosensors market in Canada 132

11.2.3 MEXICO 132
11.2.3.1 Use of biosensors to detect cardiovascular disorders propels market growth in Mexico 132
11.3 EUROPE 133
FIGURE 38 SNAPSHOT: BIOSENSORS MARKET IN EUROPE 134
TABLE 94 BIOSENSORS MARKET IN EUROPE, BY APPLICATION,
2017–2020 (USD BILLION) 135
TABLE 95 BIOSENSORS MARKET IN EUROPE, BY APPLICATION,
2021–2026 (USD BILLION) 135
TABLE 96 BIOSENSORS MARKET IN EUROPE, BY POC APPLICATION,
2017–2020 (USD MILLION) 135
TABLE 97 BIOSENSORS MARKET IN EUROPE, BY POC APPLICATION,
2021–2026 (USD MILLION) 136
TABLE 98 BIOSENSORS MARKET IN EUROPE, BY HOME DIAGNOSTICS APPLICATION, 2017–2020 (USD MILLION) 136
TABLE 99 BIOSENSORS MARKET IN EUROPE, BY HOME DIAGNOSTICS APPLICATION, 2021–2026 (USD MILLION) 136
TABLE 100 BIOSENSORS MARKET IN EUROPE, BY TYPE, 2017–2020 (USD BILLION) 137
TABLE 101 BIOSENSORS MARKET IN EUROPE, BY TYPE, 2021–2026 (USD BILLION) 137
TABLE 102 BIOSENSORS MARKET IN EUROPE, BY PRODUCT, 2017–2020 (USD BILLION) 137
TABLE 103 BIOSENSORS MARKET IN EUROPE, BY PRODUCT, 2021–2026 (USD BILLION) 137
TABLE 104 BIOSENSORS MARKET IN EUROPE, BY COUNTRY, 2017–2020 (USD BILLION) 138
TABLE 105 BIOSENSORS MARKET IN EUROPE, BY COUNTRY, 2021–2026 (USD BILLION) 138
11.3.1 GERMANY 138
11.3.1.1 Monitoring of chronic diseases to escalate biosensors market growth 138
11.3.2 FRANCE 138
11.3.2.1 Technological advancements in healthcare systems drive growth of market in France 138
11.3.3 UK 139
11.3.3.1 Rising cardiac diseases and aging population are factors driving market growth in UK 139
11.3.4 ITALY 139
11.3.4.1 Growing private sector results in increasing demand for biosensors for various applications 139
11.3.5 REST OF EUROPE 139
11.4 APAC 140
FIGURE 39 SNAPSHOT OF BIOSENSORS MARKET IN APAC 141
TABLE 106 BIOSENSORS MARKET IN APAC, BY APPLICATION,
2017–2020 (USD BILLION) 142
TABLE 107 BIOSENSORS MARKET IN APAC, BY APPLICATION,
2021–2026 (USD BILLION) 142
TABLE 108 BIOSENSORS MARKET IN APAC, BY POC APPLICATION,
2017–2020 (USD MILLION) 142
TABLE 109 BIOSENSORS MARKET IN APAC, BY POC APPLICATION,
2021–2026 (USD MILLION) 143
TABLE 110 BIOSENSORS MARKET IN APAC, BY HOME DIAGNOSTICS APPLICATION, 2017–2020 (USD MILLION) 143
TABLE 111 BIOSENSORS MARKET IN APAC, BY HOME DIAGNOSTICS APPLICATION, 2021–2026 (USD MILLION) 143
TABLE 112 BIOSENSORS MARKET IN APAC, BY TYPE, 2017–2020 (USD BILLION) 144
TABLE 113 BIOSENSORS MARKET IN APAC, BY TYPE, 2021–2026 (USD BILLION) 144
TABLE 114 BIOSENSORS MARKET IN APAC, BY PRODUCT, 2017–2020 (USD BILLION) 144
TABLE 115 BIOSENSORS MARKET IN APAC, BY PRODUCT, 2021–2026 (USD BILLION) 144
FIGURE 40 BIOSENSORS MARKET IN CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 145
TABLE 116 BIOSENSORS MARKET IN APAC, BY COUNTRY, 2017–2020 (USD BILLION) 145
TABLE 117 BIOSENSORS MARKET IN APAC, BY COUNTRY, 2021–2026 (USD BILLION) 145
11.4.1 CHINA 146
11.4.1.1 Government initiatives toward creating better healthcare products and services likely to propel biosensors market growth in China 146
11.4.2 JAPAN 146
11.4.2.1 Increase in standard of living, rise in health awareness, and surge in aging population are key factors driving growth of biosensors market in Japan 146
11.4.3 INDIA 146
11.4.3.1 Growing population in India escalates demand for biosensors for healthcare services 146
11.4.4 REST OF APAC 146
11.5 ROW 147
TABLE 118 BIOSENSORS MARKET IN ROW, BY APPLICATION,
2017–2020 (USD MILLION) 147
TABLE 119 BIOSENSORS MARKET IN ROW, BY APPLICATION,
2021–2026 (USD MILLION) 147
TABLE 120 BIOSENSORS MARKET IN ROW, BY POC APPLICATION,
2017–2020 (USD MILLION) 148
TABLE 121 BIOSENSORS MARKET IN ROW, BY POC APPLICATION,
2021–2026 (USD MILLION) 148
TABLE 122 BIOSENSORS MARKET IN ROW, BY HOME DIAGNOSTICS APPLICATION, 2017–2020 (USD MILLION) 148
TABLE 123 BIOSENSORS MARKET IN ROW, BY HOME DIAGNOSTICS APPLICATION, 2021–2026 (USD MILLION) 149
TABLE 124 BIOSENSORS MARKET IN ROW, BY TYPE, 2017–2020 (USD BILLION) 149
TABLE 125 BIOSENSORS MARKET IN ROW, BY TYPE, 2021–2026 (USD BILLION) 149
TABLE 126 BIOSENSORS MARKET IN ROW, BY PRODUCT, 2017–2020 (USD BILLION) 149
TABLE 127 BIOSENSORS MARKET IN ROW, BY PRODUCT, 2021–2026 (USD BILLION) 150
TABLE 128 BIOSENSORS MARKET IN ROW, BY COUNTRY, 2017–2020 (USD BILLION) 150
TABLE 129 BIOSENSORS MARKET IN ROW, BY COUNTRY, 2021–2026 (USD BILLION) 150
11.5.1 SOUTH AMERICA 150
11.5.1.1 Growing environment-related concerns have boosted adoption of biosensors for environmental monitoring applications in South America 150

11.5.2 MIDDLE EAST AND AFRICA 151
11.5.2.1 Significant government support and financial support from global firms for adoption of POC testing kits will drive market for biosensors across Middle East and Africa 151
11.6 IMPACT OF COVID-19 151
12 COMPETITIVE LANDSCAPE 152
12.1 OVERVIEW 152
12.2 MARKET EVALUATION FRAMEWORK 152
TABLE 130 OVERVIEW OF STRATEGIES DEPLOYED BY KEY BIOSENSORS PLAYERS 152
12.2.1 PRODUCT PORTFOLIO 153
12.2.2 REGIONAL FOCUS 153
12.2.3 MANUFACTURING FOOTPRINT 153
12.2.4 ORGANIC/INORGANIC GROWTH STRATEGIES 153
12.3 REVENUE ANALYSIS OF LEADING PLAYERS (2016–2020) 153
FIGURE 41 FIVE YEAR REVENUE ANALYSIS OF TOP 5 PLAYERS IN BIOSENSORS MARKET 153
12.4 MARKET SHARE ANALYSIS: BIOSENSORS MARKET, 2020 154
TABLE 131 DEGREE OF COMPETITION 154
12.5 COMPANY EVALUATION MATRIX 156
12.5.1 STAR 156
12.5.2 EMERGING LEADER 156
12.5.3 PERVASIVE 156
12.5.4 PARTICIPANT 156
FIGURE 42 COMPANY EVALUATION MATRIX, 2020 157
12.6 STARTUP EVALUATION MATRIX 158
TABLE 132 LIST OF STARTUP COMPANIES IN BIOSENSORS MARKET 158
12.6.1 PROGRESSIVE COMPANY 159
12.6.2 RESPONSIVE COMPANY 159
12.6.3 DYNAMIC COMPANY 159
12.6.4 STARTING BLOCK 160
FIGURE 43 STARTUP (SME) EVALUATION MATRIX, 2020 160
12.7 COMPANY PRODUCT FOOTPRINT 161
TABLE 133 COMPANY PRODUCT FOOTPRINT 161
TABLE 134 FOOTPRINT OF DIFFERENT SENSOR TYPES BY DIFFERENT COMPANIES 162
TABLE 135 FOOTPRINT OF DIFFERENT COMPANIES ACROSS DIFFERENT APPLICATIONS 163
TABLE 136 REGIONAL FOOTPRINT OF DIFFERENT COMPANIES 164
12.8 COMPETITIVE SITUATIONS AND TRENDS 165
12.8.1 PRODUCT LAUNCHES AND DEVELOPMENTS 165
TABLE 137 PRODUCT LAUNCHES AND DEVELOPMENTS, 2020 165
12.8.2 DEALS 166
TABLE 138 DEALS, 2019–2021 166

13 COMPANY PROFILES 169
(Business Overview, Products Offered, Recent Developments, COVID-19 related developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1 KEY PLAYERS 169
13.1.1 ABBOTT 169
TABLE 139 ABBOTT: BUSINESS OVERVIEW 169
FIGURE 44 ABBOTT: COMPANY SNAPSHOT 170
13.1.2 ROCHE 174
TABLE 140 ROCHE: BUSINESS OVERVIEW 174
FIGURE 45 ROCHE: COMPANY SNAPSHOT 175
13.1.3 MEDTRONIC 178
TABLE 141 MEDTRONIC: BUSINESS OVERVIEW 178
FIGURE 46 MEDTRONIC: COMPANY SNAPSHOT 179
13.1.4 BIO-RAD LABORATORIES 182
TABLE 142 BIO-RAD LABORATORIES: BUSINESS OVERVIEW 182
FIGURE 47 BIO-RAD LABORATORIES: COMPANY SNAPSHOT 183
13.1.5 DUPONT 186
TABLE 143 DUPONT: BUSINESS OVERVIEW 186
FIGURE 48 DUPONT: COMPANY SNAPSHOT 187
13.1.6 BIOSENSORS INTERNATIONAL GROUP 190
TABLE 144 BIOSENSORS INTERNATIONAL GROUP: BUSINESS OVERVIEW 190
13.1.7 CYTIVA 192
TABLE 145 CYTIVA: BUSINESS OVERVIEW 192
13.1.8 DEXCOM 195
TABLE 146 DEXCOM: BUSINESS OVERVIEW 195
FIGURE 49 DEXCOM: COMPANY SNAPSHOT 196
13.1.9 LIFESCAN 198
TABLE 147 LIFESCAN: BUSINESS OVERVIEW 198
13.1.10 MASIMO 200
TABLE 148 MASIMO: BUSINESS OVERVIEW 200
FIGURE 50 MASIMO: COMPANY SNAPSHOT 201
13.1.11 NOVA BIOMEDICAL 204
TABLE 149 NOVA BIOMEDICAL: BUSINESS OVERVIEW 204
13.1.12 UNIVERSAL BIOSENSORS 207
TABLE 150 UNIVERSAL BIOSENSORS: BUSINESS OVERVIEW 207
FIGURE 51 UNIVERSAL BIOSENSORS: COMPANY SNAPSHOT 208
13.2 OTHER KEY PLAYERS 210
13.2.1 ACON LABORATORIES 210
13.2.2 CARDEA BIO 211
13.2.3 CONDUCTIVE TECHNOLOGIES 212
13.2.4 EARLYSENSE 212
13.2.5 EASTPRINT INCORPORATED 213
13.2.6 IST AG 214
13.2.7 LIFESIGNALS 215
13.2.8 NEUROSKY 216
13.2.9 PINNACLE TECHNOLOGY 217
13.2.10 SD BIOSENSOR 218
13.2.11 VITALCONNECT 219
13.2.12 XSENSIO 220
13.2.13 ZIMMER AND PEACOCK 221
*Details on Business Overview, Products Offered, Recent Developments, COVID-19 related developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 APPENDIX 222
14.1 DISCUSSION GUIDE 222
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 225
14.3 AVAILABLE CUSTOMIZATIONS 227
14.4 RELATED REPORTS 227
14.5 AUTHOR DETAILS 228



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(SE3097 )"世界のバイオセンサー市場(~2026年):種類別、製品別(ウェアラブル、非ウェアラブル)、技術別、用途別(POC、家庭診断、研究所、環境モニタリング、食品&飲料、バイオディフェンス)、地域別" (英文:Biosensors Market with COVID-19 Impact by Type, Product (Wearable, Non-wearable), Technology, Application (POC, Home Diagnostics, Research Lab, Environmental Monitoring, Food & Beverages, Biodefense) and Region - Global Forecast to 2026)はMarketsandMarkets社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。